The clustering of cardiovascular risk factors in MetS indicated that multiple complex metabolic reactions involved in glycotoxicity, lipotoxicity, altered insulin signaling, increased cytokine activity and interstitial deposition of triacylglycerol, which may all directly or indirectly to impact on myocardial function[17, 18]. The gene discussed is INS; the disease is metabolic syndrome.